|
J Biol Chem, Vol. 273, Issue 6, 3408-3414, February 6, 1998
Cell Density Modulates Protein-tyrosine Phosphorylation*
David B.
Batt and
Thomas M.
Roberts
From the Department of Cancer Biology, Dana Farber Cancer Institute
and Department of Pathology, Harvard Medical School,
Boston, Massachusetts 02115
 |
ABSTRACT |
The growth of normal cells is arrested at
saturating cell density in a process termed contact inhibition. An
understanding of how cells communicate their contact with one another
is critical for determining how cancers develop and spread. Because the
molecular details of how fibroblasts communicate density changes are
unclear, we examined cell density itself as a source of signaling
events rather than examine specific receptors. A technique was
developed to measure tyrosine phosphorylation acutely as a function of
cell density. The tyrosine phosphorylation of a number of proteins was
found to be modified in response to cell density. Three of these
proteins were identified as Src, paxillin, and focal adhesion kinase
(FAK), all of which show an increase in their tyrosine phosphate levels
with increasing density. All of these proteins are found in focal
adhesions, and both FAK and paxillin are believed to be localized
exclusively in focal adhesions. Thus, changing cell density alters
tyrosine phosphorylation of focal adhesion components.
 |
INTRODUCTION |
Cells need to sense their environment to make decisions.
Environmental signals are sensed by receptors that bind ligands such as
growth factors, extracellular matrix, or cell surface molecules on
adjacent cells. These receptors in turn activate signaling pathways,
which communicate the state of the environment to the nucleus so that
decisions on growth, differentiation, motility, etc. can be made. The
importance of these pathways is made evident by the hallmarks of
transformation: loss of requirements for growth factors, extracellular
matrix (ECM),1 and contact
inhibition.
Signals from the environment can be positive or negative for growth.
The study of positive signals such as growth factors has led to a
general model where activation of the receptor by the ligand leads to
autophosphorylation on tyrosine residues of the receptor. These
phosphorylated residues serve as substrates to assemble an active
signaling complex. The immediate result of the activation of these
receptor-coupled enzymes is the activation of kinase cascades, which
allow the amplification of the signal through the pathway. In each
case, the end result of the kinase cascade is modified transcription of
select genes in the nucleus. The extracellular matrix also serves as a
positive signal for growth. The best characterized extracellular matrix
receptors are integrins. Integrins are also important in cell migration and differentiation. Contact of fibroblasts with ECM proteins leads to
the activation of multiple signaling pathways, including the activation
of protein-tyrosine kinases (1, 2). In fact, many different integrins
can regulate protein-tyrosine kinases (2). In fibroblasts, the
interaction of ECM and integrins results in the increased activity of
the tyrosine kinase pp125 FAK (3). Increased FAK activity results in
the tyrosine phosphorylation of FAK and the recruitment of signaling
proteins such as Src and paxillin to FAK.
Although signals in response to growth factors and extracellular matrix
have long been studied, the negative growth signals resulting from cell
contact have received attention only more recently. Most of what is
known about the signaling resulting form cell-cell contact comes from
the study of epithelial cells. Epithelial cells have transmembrane
receptors, cadherins, which are important for communicating signals
generated at sites of cell-cell contact. The current model suggests
that cadherins on one cell can interact with those on another cell and
could serve as a molecular probe for cell density. Catenins form a
complex with cytoplasmic tail of cadherins (4, 5) which can be
phosphorylated by tyrosine kinases including MET, epidermal growth
factor receptor, and Src (6, 7). Evidence that this signaling pathway
plays a critical role in contact inhibition comes from studies of the Drosophila DLG protein. The DLG protein is found at
cell-cell contacts and is homologous to ZO-1 and ZO-2 found in tight
junctions (8). Mutations in the DLG protein result in overgrowth of the imaginal disc cells, indicating a role in tissue growth control and
signal transduction (9). Although fibroblasts also exhibit contact
inhibition, much less is known about the molecular signaling involved.
The complex signaling pathways involved in both positive and negative
growth signals rely, in part, on tyrosine phosphorylation. Because of
the critical role phosphorylation plays in communicating aspects of the
cell's environment, we examined whether cell density in culture could
affect tyrosine phosphorylation. Because it is unclear how fibroblasts
communicate density changes, we examined cell density itself as a
source of signaling events rather than examining specific receptors and
their downstream tyrosine-phosphorylated proteins. By plating cells at
increasing densities, we could manipulate the amount of cell-cell
contact and observe the phosphotyrosine profiles of cells plated at
increasing densities. Using this approach, we have identified several
proteins for which phosphorylation state is modified by cell density as
a method to identify the phosphorylated proteins responsible for
signaling cell contact. Here, we begin the identification and initial
molecular characterization of some of the proteins for which
phosphorylation changes in response to plating densities.
 |
MATERIALS AND METHODS |
Cell Culture--
Balb 3T3 fibroblasts were grown in Dulbecco's
modified Eagle's medium supplemented with 10% calf serum. Cells were
grown to confluence. Confluent cells were trypsinized and replated in
fresh medium (Dulbecco's modified Eagle's medium supplemented with
10% calf serum) at 0.5, 1, 3, or 5 × 106 cells/10-cm
plastic tissue culture dish. Pre or P lanes on
figures represent samples from confluent cells before trypsinization
and replating. These cells have been treated with fresh medium to be
consistent with the treatment of the replated cells. Cells were allowed
to attach to the dish for 2.5 h. Gradual confluence studies were
done by plating Balb 3T3 cells at 10% confluence and harvesting when
cells were at different levels of confluence. Cell medium was changed
at least 24 h before harvest to avoid serum effects.
Harvesting Cell Lysate--
Cells were washed twice with
ice-cold phosphate-buffered saline to remove medium. Cells were lysed
at 0 °C on the plate with Nonidet P-40 lysis buffer (1% Nonidet
P-40, 20 mM Tris, pH 8.0, 10% glycerol, 137 mM
NaCl, 1 mM phenylmethylsulfonyl fluoride, 0.15 unit/µl
aprotinin, 20 µM leupeptin, 1 mM
Na3VO4, 10 mM NaF). Insoluble
material was removed by a 3-min spin at 12,000 × g. The Nonidet P-40-soluble fraction was used for Western blots and immunoprecipitations. For the Src Western blot, the Nonidet
P-40-insoluble fraction was re-extracted with RIPA (50 mM
Tris, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% SDS), creating the Nonidet
P-40-insoluble/RIPA-soluble fraction.
Western Blots--
Equal microgram amounts of each lysate
(generally about 25 µg) were separated by discontinuous SDS-PAGE.
Transfer of proteins to nitrocellulose was accomplished by
electrotransfer in transfer buffer (39 mM glycine, 48 mM Tris, 0.37% SDS) at 400 mA for 4 h at 4 °C.
Nitrocellulose was blocked by 5% powdered milk in TBST (10 mM Tris, pH 8, 150 mM NaCl, 0.05% Tween 20).
Primary antibodies were diluted in 1 × TBST and incubated for
1 h at room temperature. Primary antibodies against FAK and
paxillin were obtained form Transduction Laboratories and used
according to the manufacturer. Anti-phosphotyrosine antibody (4G10) and
anti-FAK antibody for immunoprecipitation were from UBI. Detection of
Src was through anti-Src 327 antibody provided by Dr. Brugge, Harvard
Medical School, and was diluted to 1 µg/ml. Blots in which Src was to be detected contained 100 µg of lysate. Secondary antibodies were from Amersham Life Science and were diluted 1:5000. Proteins were detected using Amersham's ECL kit for Westerns. ECL was performed as
suggested by the manufacturer.
Quantitative Western Blot--
Precipitation of paxillin was
accomplished by mixing 120 µg of lysate with 4 µg of anti-paxillin
(Transduction Laboratories). Immunocomplexes were collected by the
addition of protein A-Sepharose beads (Pharmacia Biotech Inc.). Washed
complexes were separated by SDS-PAGE and transferred to nitrocellulose
blots as described above. Nitrocellulose blots were first probed with
anti-phosphotyrosine antibody (4G10). Secondary antibodies coupled to
alkaline phosphatase were diluted to 1:5000 (Promega).
Tyrosine-phosphorylated paxillin was detected and quantitated by
fluorescence emission using Attophos substrate (JBL Scientific) and a
FluorImager (Molecular Dynamics). The blot was stripped of antibody and
reprobed with anti-paxillin antibody (Transduction Laboratories) in the
same manner. Using the numbers generated by the FluorImager, a -fold
increase in tyrosine phosphate level of paxillin and a -fold increase
in paxillin protein level were calculated.
Immunoprecipitations--
The precipitation of paxillin or
tyrosine-phosphorylated proteins was accomplished by mixing 200 µg of
lysate with either 4 µg of anti-paxillin (Transduction Laboratories)
or 60 µg of 4G10. Immunocomplexes were collected by the addition of
protein A-Sepharose beads (Pharmacia). Immunoprecipitations were washed twice with 0.5 M LiCl, 0.1 M Tris, pH 8, and
once with phosphate-buffered saline. Immunoprecipitations in Fig. 3
were accomplished by mixing 240 µg of lysate with 16.5 µg of 4G10
or 4.5 µg of anti-FAK monoclonal antibody (UBI). Complexes were
precipitated by the addition of anti-mouse Sepharose beads
(Zymed Laboratories Inc.). Beads were washed three
times with lysis buffer.
Kinase Assay--
Src was immunoprecipitated from 650 µg of
lysate by the addition of 3.5 µg of 327 Src antibody and protein
A-Sepharose. The washes and kinase assay were performed as described
(10).
Phosphatase Treatment--
Paxillin immunoprecipitates were
incubated with phosphatase buffer (50 mM Tris-HCl (pH
7.8), 5 mM dithiothreitol, 2 mM
MnCl2, 100 µg/ml bovine serum albumin) with or without
600 units of phosphatase for 30 min at 30 °C.
 |
RESULTS |
To gain insights into the signaling pathway used by fibroblasts to
communicate cell-cell contact, we used a method in which confluent
cells were trypsinized and replated at various densities, thus
providing a method to control the amount of contact the cells have with
each other. At the lowest density (0.5 × 106
cells/10-cm dish), cells exhibit little contact with other cells. At
the highest density (5 × 106 cells/10-cm dish), each
cell was in contact with several neighbors. Intermediate densities of 1 and 3 × 106 cells/10-cm dish yielded levels of
contact consistent with their densities. Cells were allowed to interact
for a fixed time (2.5 h) before they were harvested. This method
reduces the number of variables such as medium replacement, which are
necessary in experiments where cells grow together over several days,
and allows for the detection of transient signals which could be lost
over time. Because tyrosine-phosphorylated proteins have been shown to
be important in many cell signaling pathways, we evaluated the
phosphotyrosine pattern of the lysates obtained from cells in which the
level of cell-cell contact was manipulated as a means to understand the
molecular consequences of contact. Using this method, we have found
differences in the phosphotyrosine pattern between lysates harvested
from cells in which contact was minimal compared with cells that
contacted many neighbors. Fig. 1 shows a
typical phosphotyrosine pattern obtained from lysates prepared at
2.5 h after replating cells at increasing densities. The pattern can be divided into three categories: bands in which the
phosphotyrosine signal increases with cell density, bands in which the
phosphotyrosine signal seems to decrease with increasing cell density,
and bands that do not respond to changes in cell density. Proteins of
120, 62, 45, and 20-30 kDa have increased phosphotyrosine levels in response to higher cell density. Other proteins such as a 68- and
58-kDa protein seem to have levels of phosphotyrosine that decrease
with increasing cell density. Still other proteins do not appear to
have changes in their phosphotyrosine content as a result of increased
plating density (92 kDa).

View larger version (89K):
[in this window]
[in a new window]
|
Fig. 1.
Protein phosphotyrosine changes as density
increases. Balb 3T3 fibroblasts were platted onto 10-cm tissue
culture dishes at 0.5 × 106, 1 × 106, 3 × 106, and 5 × 106 cells/dish. At 2.5 h after platting cells were
harvested, lysates separated on 10% SDS-PAGE, and proteins transferred
to nitrocellulose. Tyrosine-phosphorylated proteins were detected with
the mAb 4G10. Approximate sizes of molecular size markers (200, 97, 68, 43, 29, and 18 kDa) are shown to the left. Equal amounts of
protein (25 µg) from lysates prepared from cells plated at the
densities indicated at the bottom of each lane (× 106)
were loaded. n = 7.
|
|
Identification of Proteins--
By comparing the molecular weight
of the unknown protein to the molecular weights of known
tyrosine-phosphorylated proteins, a list of candidates was generated.
Antibodies against the candidates were obtained to confirm or refute
the tentative assignment. In this manner, we have identified three of
the bands as paxillin, pp60c-src, and FAK.
Density-dependent Effects on
pp60c-src--
Because we had observed changes in tyrosine
phosphorylation as a function of cell density, it was reasonable to
speculate that tyrosine kinases might be activated. Kinases known to be modulated by cell-cell and cell substrate contacts include
pp60c-src and FAK (11-15). As one of the bands
that increased with density in the anti-phosphotyrosine (4G10) blot was
about 60 kDa and aligned when the blot was reprobed with anti-Src
antibodies, we examined the effects that different densities had on the
activity and distribution of the tyrosine kinase
pp60c-src. Several density-dependent
effects were observed. First, replating cells at higher densities
shifted pp60c-src to a higher apparent molecular
weight (Fig. 2). Lysates from confluent
cells, before replating, show a doublet when probed with antibodies
against pp60c-src. Both bands of the doublet are of
equal intensity. The Src antibody used in these experiments is directed
to the SH3 domain of Src and recognizes c-Src as well as v-Src and has
not been reported to show a preference for different forms. When cells
were replated at low densities, Src remained as a doublet, but cells
replated at high densities displayed mainly the upper band with only
traces of the lower band (Fig. 2, compare the 0.5 lane to
5 lane of Nonidet P-40-soluble fraction). Second, only the
slower migrating form was found in the Nonidet
P-40-insoluble/RIPA-soluble fraction, and this form increased in
abundance as cells were plated at increasing densities (Fig. 2, compare
the 0.5 lane to 5 lane of Nonidet
P-40-insoluble/RIPA-soluble fraction). Western blots on this fraction
also indicate that the level of Src was high just before replating.
Third, pp60c-src kinase activity increases with
increasing cell density (data not shown). To determine if
pp60c-src had increased kinase activity at higher
densities, pp60c-src autokinase assays were done on
the Nonidet P-40-soluble fractions. These results revealed that
confluent cells and those plated at low density have low levels of
kinase activity, whereas cells plated at high densities have high
activity. In summary, when cells are replated, the amount of the slower
migrating form as well as pp60c-src's kinase
activity increase with increasing density.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Src levels and solubility change with
density. Balb 3T3 cells were either untreated (PRE
lane) or trypsinized and replated at the densities (× 106 cells/plate) given below each lane. Cells were lysed
with Nonidet P-40 lysis buffer 2.5 h after replating. The
insoluble material from the Nonidet P-40 buffer was collected by
centrifugation and re-extracted with RIPA buffer, creating the Nonidet
P-40-soluble/RIPA-soluble fraction. 100 µg of each of the Nonidet
P-40-soluble lysates and 20 µg of each of the Nonidet
P-40-insoluble/RIPA-soluble lysates were used. Lysates were separated
by SDS-PAGE and transferred to nitrocellulose. A mAb (Src 327) against
Src was used for detection. Information on the cell density and
fraction used to prepare the lysates is given at the bottom.
n = 2.
|
|
FAK Phosphorylation Increases in Response to Cell Density--
The
anti-phosphotyrosine blot (Fig. 1) showed that, after 2.5 h of
contact, a protein of about 120 kDa increased its level of tyrosine
phosphorylation in density-dependent manner. This protein
has increased tyrosine phosphorylation in both experiments in which
cells grew together gradually and experiments in which wortmannin was
used to inhibit spreading. Phosphorylation of this protein in response
to density can be observed as early as 1 h (data not shown). This
protein has been tentatively identified as focal adhesion kinase (pp125
FAK). This assignment is based on three facts. First, FAK is known to
be one of the main tyrosine-phosphorylated bands in adherent
fibroblasts. Second, blots probed with anti-phosphotyrosine (4G10),
stripped of the antibody, and reprobed with a FAK antibody display a
band at exactly the same location (data not shown). Third,
immunoprecipitations with anti-phosphotyrosine (4G10) or FAK antibodies
displayed a band of 125 kDa when probed with the anti-phosphotyrosine
antibody 4G10 (Fig. 3). Caution should be used in evaluating the levels of tyrosine-phosphorylated FAK in the
immunoprecipitation because the precipitating antibody does show
different immunoaffinity for modified forms of FAK. The protein level
of FAK does not change appreciably with changing densities (data not
shown).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
A tyrosine-phosphorylated band a 130 kDa
increases with cell density. 240 µg of lysate from each density
was immunoprecipitated by 4G10 or anti-FAK antibody and the
addition of anti-mouse Sepharose beads. The precipitate was separated
and transferred to nitrocellulose membrane. A Western blot was done
using anti-phosphotyrosine mAb 4G10. Markers (kDa) are labeled on
the left, and cell densities (× 106/plate) are
on the bottom along with the antibody used for the precipitation. n = 2. P, confluent monolayer
before replating; M, marker; IP,
immunoprecipitate.
|
|
Tyrosine-phosphorylated Paxillin Increases in a
Density-dependent Manner--
Anti-phosphotyrosine blots
of total lysates show a band at about 68 kDa (paxillin), which became
less intense as cell density increased. Upon further study, it became
clear that the level of tyrosine-phosphorylated paxillin actually
increased with cell density. This fact was masked because paxillin
undergoes heterogeneous modifications at higher cell density causing
the phosphotyrosine signal to become diffuse. Upon review of the
original anti-phosphotyrosine blots, one can see a 68-kDa band shifting
into smear at that molecular weight. This only became clear after
immunoprecipitations with 4G10 and anti-paxillin antibodies. Fig.
4A shows an
immunoprecipitation with anti-paxillin antibody followed by a Western
to detect tyrosine-phosphorylated proteins. At low density replating,
most of the tyrosine-phosphorylated paxillin is in a single band with a
light diffuse band above it, corresponding to other phosphorylated
forms. When cells are replated at the highest density, the bottom band
is missing and it has been replaced by a much more intense smear above
it. When the bottom band and the smear are taken as a whole, the
overall phosphotyrosine signal increases as density increases. The
reciprocal immunoprecipitation confirms this finding. In Fig.
4B, lysates were precipitated by anti-phosphotyrosine
antibody (4G10) and then probed with anti-paxillin antibodies. At low
density replating, the amount of tyrosine-phosphorylated paxillin is
very low, as shown by the low levels recovered by precipitation with
the anti-phosphotyrosine antibody 4G10 (Fig. 4B). When cells
are replated at high density, the amount of tyrosine-phosphorylated paxillin recovered in a 4G10 immunoprecipitation is much higher (Fig.
4B). These experiments clearly show that the amount of
tyrosine-phosphorylated paxillin increases with increased density;
however, Western blots indicated that the amount of paxillin also
increases with cell density (see below). To determine if the amount of
phosphotyrosine per paxillin molecule was increasing or whether the
increase in the phosphotyrosine signal was solely caused by the
increase in protein levels, a quantitative Western was performed. The
quantitative Western demonstrated that the level of tyrosine phosphate
per molecule of paxillin increased more than 3-fold from the lowest to
the highest density. In short, at high density replating, there are
more paxillin molecules and they contain more tyrosine phosphate than
the paxillin from cells replated at low density.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
The level of tyrosine-phosphorylated paxillin
increases with density. 200 µg of lysates obtained 2.5 h
after plating, for each density, were immunoprecipitated with a mAb
coupled to protein A-Sepharose beads. Immunoprecipitate was washed and
separated by SDS-PAGE and transferred to nitrocellulose. A,
lysates were immunoprecipitated with antibody against paxillin, and
tyrosine-phosphorylated paxillin was detected with the mAb 4G10.
Molecular weights are indicated to the left. The density of
the Balb cells (× 106) is given at the bottom.
On the right, the position of both paxillin and the heavy
chain (H.C.) of the immunoprecipitating antibody are given.
B, tyrosine-phosphorylated proteins were precipitated with
4G10, and the presence of paxillin in the precipitate was determined by
Western blot analysis with a mAb against paxillin. The density of the
Balb cells (× 106) is given at the bottom.
n = 3.
|
|
Serine/Threonine Phosphorylation and Stability of Paxillin Change
in a Density-dependent Manner--
Western blot analysis
of total cell lysates with paxillin antibodies showed that, at lower
densities, the paxillin migrated slower than paxillin from high density
replating (Fig. 5). Tyrosine phosphorylation cannot explain this result, inasmuch as paxillin is
less phosphorylated on tyrosine at low densities. One explanation was
that at low density plating cells have high levels of Ser/Thr phosphate, which is not present when cells are plated at high density.
Confluent cells have the faster migrating form of paxillin (Fig. 5),
which is converted to a much slower form if cells are replated so they
have little cell-cell contact. To confirm that these shifts were due to
Ser/Thr phosphorylations and not other forms of modification,
phosphatase treatments were done. Extracts were either treated or
untreated with protein phosphatase. Treatment collapsed higher
migrating species, as well as the slower migrating species, to a faster
migrating doublet (Fig. 6). Although the phosphatase experiment indicates that the shifts are caused by
phosphates, the data are consistent with the induction of a Ser/Thr
kinase at low cell density or with the activation of a Ser/Thr
phosphatase at high density.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 5.
Paxillin protein and phosphate levels change
with density. Lysates from each density were separated by 10%
SDS-PAGE and transferred to nitrocellulose. Paxillin was detected with a mAb against paxillin. The number of cells plated 2.5 h before harvest is given above each lane. B shows results
from an independent experiment where the lysates were separated
further, allowing the detection of several shifted paxillin forms.
n = 7.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 6.
Phosphatase treatment of paxillin.
Immunoprecipitations of paxillin from each density were either
untreated or treated with protein phosphatase. The samples were
separated on 10% SDS-PAGE and transferred to nitrocellulose. Paxillin
was detected by mAb against paxillin. Molecular weight markers are
presented to the left, and the positions of paxillin and
heavy chain (H.C.) are given to the right.
n = 2. P, confluent monolayer before
replating.
|
|
To learn more about how paxillin behaves when cells are plated at
different densities, lysates from the different densities were examined
for their levels of paxillin by Western blot. The level of paxillin is
high in confluent cells just before trypsinization and replating (Fig.
5). The amount of paxillin drops dramatically in cells replated at low
density but remains high in cells plated at high density (Fig. 5). The
loss of paxillin at low density replating is not caused by the movement
of paxillin to a Nonidet P-40-insoluble fraction because addition of
RIPA to the Nonidet P-40-insoluble fraction showed that Nonidet P-40
had extracted all the paxillin at each density examined (data not
shown). To determine if the change in paxillin levels was the result of
breakdown or increased synthesis, an [35S]methionine
pulse-chase experiment was done (data not shown). Cells were
radiolabeled before replating at the various densities, and lysates
were harvested 2.5 h later. At low density, both the 35S signal as well as the signal generated by a Western
blot were low; however, when cells were replated at high density, the
35S signal as well as the signal generated by a Western
blot remained high. This result suggests that the change in paxillin
levels is caused by breakdown at low density replating rather than
increased synthesis at high density replating.
Next, we examined if the changes in paxillin levels and Ser/Thr
phosphorylation could be detected at time points earlier than 2.5 h. At 1 h after plating, cells exhibited the paxillin shifting seen at the 2.5-h time point but did not exhibit as dramatic a level
change as that seen at the longer time point (Fig.
7). The 1-h time point most likely
represents the early phase of the paxillin turnover for several
reasons. First, the paxillin levels at the lower cell densities are
lower than the levels in the higher density cells indicating the
beginnings of the turnover. Second, several smaller fragments are
detected by the paxillin antibody in the low density lysates,
suggesting that these may be breakdown products generated by the
paxillin turnover.

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 7.
Paxillin protein and phosphate levels change
with density at earlier time points. Lysates from each density
were harvest 1 h after replating then separated by 10% SDS-PAGE
and transferred to nitrocellulose. P lane represents the
starting confluent monolayer before replating. The numbers
below other lanes represent the number of cells (× 106/plate) replated. Paxillin was detected with a mAb
against paxillin. Molecular weight markers are given to the
left. n = 4.
|
|
Distinguishing Effects of Cell Density from Those Due to Cell
Spreading--
The changes in tyrosine phosphate seen at low cell
density might in theory be due to cell spreading on the substrate, as
the sparse cells did exhibit spreading at the 2.5-h time point.
Notably, each of the molecules we have studied has been localized, at
least in part, in focal contacts. To distinguish whether the tyrosine phosphorylations we observed were due to spreading, several approaches were taken.
First, we utilized an entirely different protocol to study the density
effect. In this protocol, cells were allowed to become confluent
gradually. We plated cells at a fixed density (10%) onto fresh dishes
and harvested them over several days at different levels of confluence.
Cells were harvested at 20%, 40%, and 80% confluence. In this
method, cells have had an equal opportunity to spread at all points;
thus, differences seen should be independent of spreading. As before,
molecular consequences of contact were evaluated by the phosphotyrosine
pattern of the lysates (Fig. 8). Although
this method lacks the acute nature of our first protocol, it is
apparent that the effects of density are visible with both protocols.
This alternative approach also served to validate the methodology
used.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 8.
Phosphotyrosine profiles of cells at
different levels of confluence. Balb 3T3 fibroblasts were plated
at 10% confluence. Cells were harvested when they reached 20%, 40%,
80%, and at confluence. Nonidet P-40 lysates were separated by
SDS-PAGE and transferred to nitrocellulose. The resulting blot was
probed with anti-phosphotyrosine antibody 4G10. Numbers on
the top represent the approximate percentage of confluence.
Molecular weight markers are presented to the left. n = 4.
|
|
Finally, we made use of the chance observation that cells treated with
the PI 3-kinase inhibitor wortmannin showed a large defect in their
ability to spread on plastic tissue culture dishes (Fig.
9). Wortmannin dramatically inhibited
spreading at early time points (30-60 min). This inhibition partially
recovered by 2.5 h but still showed a large defect in spreading
(Fig. 9). Lysates were prepared at 2.5 h from cells plated at
different densities in the presence of wortmannin. These lysates were
examined for their phosphotyrosine content as before. The pattern
obtained from these lysates is similar to patterns of obtained without wortmannin (Fig. 10). This would
indicate that many proteins can become tyrosine-phosphorylated in
response to density in a PI 3-kinase-independent manner.

View larger version (122K):
[in this window]
[in a new window]
|
Fig. 9.
Photomicrographs of wortmannin treated Balb
cells. Balb cells were replated onto tissue culture plates at
about 2 × 106 cells/plate either in the presence of
100 nM wortmannin or not. Pictures were taken after
2.5 h. n = 2.
|
|

View larger version (82K):
[in this window]
[in a new window]
|
Fig. 10.
Anti-phosphotyrosine profile of
wortmannin-treated cells. Balb 3T3 fibroblasts were plated onto
10-cm tissue culture dishes at 0.5 × 106, 1 × 106, 3 × 106, 5 × 106
cells/dish in the presence of 100 nM wortmannin
(W) or untreated (U.T.). The Pre plate
represents cells before the replating. 2.5 h after plating cells
were harvested, lysates separated on 10% SDS-PAGE, and proteins
transferred to nitrocellulose. Tyrosine-phosphorylated proteins were
detected with the mAb 4G10. Approximate sizes of molecular weight
markers (97, 68, 43, and 29 kDa) are shown to the right.
n = 2.
|
|
 |
DISCUSSION |
Cells live in a milieu of signals that must be interpreted so the
cell can respond correctly to its environment. Complex signals such as
stress, growth factor availability, the presence of extracellular matrix, and the presence of other cells among others must be translated into actions such as proliferation, growth arrest, differentiation, and
migration. Many of these messages are sent from receptors on the cell
surface to the nucleus via a complex network of signaling proteins that
communicate with each other by phosphorylation. Although it has been
known for years that most cells exhibit contact inhibition, the exact
molecular details of this event remain unclear. Because the cell relies
so heavily on tyrosine phosphorylation to communicate changes in the
environment, we examined the changes in tyrosine phosphorylation
patterns as a function of cell density. This was done by plating
fibroblasts onto plastic tissue culture dishes at increasing density
such that cells plated at the lowest density had few cell-cell contacts
and cells at the highest density had a high level of cell-cell contact.
As can be seen in Fig. 1 (phosphotyrosine blot), there are proteins for
which tyrosine phosphate levels change in response to cell density. To
our knowledge, this is the first time a protein phosphotyrosine
profile, as a function of density, has been reported.
Increased tyrosine phosphorylation of multiple proteins suggests the
activation of tyrosine kinases. In our density-dependent system, Src becomes more active as a kinase and also becomes more Nonidet P-40-insoluble as plating density increases. It is unclear why
Src, which can stimulate growth, is activated at high density. It
should be noted that the increase in Src activity after replating at
high density is most likely a transient signal. The signal is assumed
to be transient because Src activity is low in confluent cells but is
activated if cells are replated at high density. Similar results were
seen in platelet activation, which also results in both the activation
of Src and its recruitment to an Nonidet P-40-insoluble fraction (16).
Recently, cell density has been shown to modulate the activity and the
subcellular location of Src (17). Src has long been known to play a
role in multiple signal transduction pathways. Environmental signals
such as oxidative stress, many growth factors, cytokines, thrombin,
lysophosphatic acid, and extracellular matrix can modulate Src or Src
family members (18). Src then mediates these environmental signals by
activating different downstream pathways, including the stress pathway,
Ras pathway, Myc, PI 3-kinase, and cytoskeletal reorganization (18).
Recently, Src has been implicating in playing roles both in cell-cell
as well as cell-substrate interactions. Src and other protein-tyrosine
kinases such as MET and the epidermal growth factor receptor are
thought to phosphorylate components of the cadherin-catenin complex,
thereby effecting adherens junctions and cell-cell contact in
epithelial cells (12, 14). At the moment, however, we can not determine
whether the density-dependent activation of Src originates
at sites of cell-cell contact or at other sites such as focal adhesions
(see below).
Both paxillin and FAK, identified in this study as having increased
tyrosine phosphorylation in response to increased cell density, are
localized to focal adhesions. FAK, the tyrosine phosphorylation of
which is generally associated with its activation, becomes tyrosine-phosphorylated in response to integrin engagement (11, 19, 20)
and growth factors such as platelet-derived growth factor (21, 22). The
increase in tyrosine phosphorylation that we observe can be seen at the
2.5-h time point as well as in the gradual confluence and wortmannin
experiments, suggesting that this is the result of contact rather than
spreading. Paxillin, a proximal signaling target for tyrosine kinases
at the membrane, also shows increased tyrosine phosphorylation as cell
density increases. Paxillin, like FAK, becomes phosphorylated in
response to many extracellular events beside the one reported here,
including integrin-mediated adhesion (11, 23-28). Tyrosine
phosphorylation of paxillin and FAK are important for the assembly of
functional signaling complexes. In fact, paxillin binds several known
signaling factors, including FAK (29), CSK (30) Src (31), and Crk (32).
Both paxillin and FAK can become tyrosine-phosphorylated in response to
integrin engagement as well as growth factors such as platelet-derived
growth factor. In fact, it now seems clear that signals from growth
factor receptors and from integrins act synergistically in many
signaling pathways. The data reported here suggest that cell density
could modulate these signals by changing the phosphorylation state of
proteins in focal adhesions. One would expect that signals such as
contact with ECM, the presence of growth factors, and the density of
cells would converge at some level so that a decision as to whether to
divide or not could be reached.
Could events other than cell-cell contact be the cause of
phosphotyrosine changes observed here? Spreading could effect our results inasmuch as cells plated at high densities are less able to
spread then those plated sparsely. To address whether some of the
changes described may have been caused by spreading rather than
cell-cell contact, we have examined the density effects as the cells
become confluent over several days. This method removes the effect of
spreading and gave us results very similar to our original method
(compare Figs. 1 and 8). Finally, we noticed that the drug wortmannin
dramatically inhibits spreading and we have begun to use it to inhibit
spreading. These different methods allow us to rule out a causal role
for spreading in most of the observed tyrosine phosphorylations. A
second mechanism other than cell-cell contact which could affect our
results involves the secretion of extracellular matrix components by
the newly plated fibroblasts. At high cell densities, more matrix might
be laid down by the cells; this in turn might lead to higher integrin engagement, resulting in the activation of FAK etc. However, our cells
were plated in medium containing serum and therefore ECM should have
been present. Furthermore, we found that our results were unchanged
when we plated cells directly onto fibronectin coated plates (data not
shown). Thus, although it remains possible that factors other than
cell-cell contact play a role in our observations, cell-cell contact
remains the simplest explanation given the data.
Although the tyrosine phosphorylations that we see are likely due to
cell density, they could be caused by cell-cell contact and the
signaling generated by this contact or by other phenomenon related to
density. Several models can be envisioned for how cells communicate
their density. One way in which this information could be transmitted
is through cell surface receptors. This system might consist of
receptors that could interact with a ligand on other cells. Interaction
of these "density" receptors would start a tyrosine phosphorylation
cascade and serve as a molecular probe for cell density. The activation
of the density receptor would activate Src and FAK and result in the
tyrosine phosphorylation of paxillin and other proteins. Alternatively,
receptors at points of cell-cell contact may be modulating signaling
molecules in the focal adhesions. We have not yet identified many of
the tyrosine-phosphorylated proteins shown in Fig. 1, and it remains
possible that one of these proteins is the density receptor. In human
fibroblasts, a density-dependent receptor has been reported
(33). Human fibroblasts have a receptor called contactinhibin receptor,
which is important in contact inhibition (33). The receptor binds to
contactinhibin, its membrane-bound ligand, located on adjacent cells
and mediates growth inhibition. The contactinhibin receptor can be
serine/threonine-phosphorylated, and this modification results in a
lower affinity for its ligand (33). Neither the receptor nor the
membrane-bound ligand were reported to have kinase activity.
Density might be sensed by gradual loss of substrate contact area or
cell shape changes as the cell becomes confluent. As cells become more
confluent, the area of substrate each cell has to interact with
decreases. Cell density, therefore, could be sensed by the gradual loss
or modification of integrin-extracellular matrix interactions as the
area of substrate per cell decreases. Our data, however, indicate that
both FAK and paxillin have increased tyrosine phosphorylation in
response to increased density. Because decreased area might be expected
to lead to fewer focal contacts, one might naively expect that tyrosine
kinase activity at focal adhesions would decrease. However, higher cell
density may result in hyperactive signaling from the remaining focal
adhesions. Finally, cell density could affect signals emanating from
focal adhesions by altering the cells shape (34, 35). As density
increases, cells are forced to share the surface area forcing them to
adopt a tall and narrow shape. Shape changes can affect DNA synthesis (34, 35) and might affect tyrosine phosphorylation in some manner
currently not understood.
Normal cells must integrate may aspects of their environment, chief
among them whether they are in contact with substrate and or cells. To
characterize contact inhibition on a molecular level, we have mapped
the overall tyrosine phosphate pattern as cell density increases and
have begun to identify those proteins for which pattern changes in
response to density. To our surprise, the first three proteins that we
have identified are generally thought of as focal adhesion proteins.
One interpretation of our data is that cell-cell contacts modify the
relation between cells and the substratum by altering the signaling
from focal adhesions. Identification of the remaining proteins should
help understand some of the molecular events involved in contact
inhibition.
 |
ACKNOWLEDGEMENTS |
We thank Donald Ingber, Helen McNamee,
Ibrahim Aksoy, and H. Toni Jun for helpful discussions and
comments.
 |
FOOTNOTES |
*
This work was supported by Postdoctoral Fellowship
GM18214-01 (to D. B.) and Grant CA43803-10 (to T. R.) from
the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Cancer
Biology, Dana Farber Cancer Institute, 44 Binney St., Boston, MA 02115. Tel.: 617-632-3048; Fax: 617-632-4770; E-mail:
thomas_roberts{at}dfci.harvard.edu.
1
The abbreviations used are: ECM, extracellular
matrix; FAK, focal adhesion kinase; PAGE, polyacrylamide gel
electrophoresis; PI 3-kinase, phosphatidylinositol 3-kinase; mAb,
monoclonal antibody; RIPA, radioimmune precipitation buffer; TBST,
Tris-buffered saline with Tween 20.
 |
REFERENCES |
-
Guan, J. L.,
Trevithick, J. E.,
and Hynes, R. O.
(1991)
Cell Regul.
2,
951-964[Medline]
[Order article via Infotrieve]
-
Schwartz, M. A.,
Schaller, M. D.,
and Ginsberg, M. H.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
549-599 [CrossRef][Medline]
[Order article via Infotrieve]
-
Guan, J. L.,
and Shalloway, D.
(1992)
Nature
358,
690-692[CrossRef][Medline]
[Order article via Infotrieve]
-
Ozawa, M.,
and Kemler, R.
(1992)
J. Cell Biol.
116,
989-996[Abstract/Free Full Text]
-
Gumbiner, B. M.,
and McCrea, P. D.
(1993)
J. Cell Sci. Suppl.
17,
155-158[Abstract]
-
Shibamoto, S.,
Hayakawa, M.,
Takeuchi, K.,
Hori, T.,
Oku, N.,
Miyazawa, K.,
Kitamura, N.,
Takeichi, M.,
and Ito, F.
(1994)
Cell Adhes. Commun.
1,
295-305[Medline]
[Order article via Infotrieve]
-
Kemler, R.
(1993)
Trends Genet.
9,
317-321[CrossRef][Medline]
[Order article via Infotrieve]
-
Gumbiner, B. M.
(1996)
Cell
84,
345-357[CrossRef][Medline]
[Order article via Infotrieve]
-
Bryant, P. J., Watson, K. L., Justice, R. W., and Woods,
D. F. (1993) Development, Suppl. 239-249
-
Rusanescu, G.,
Qi, H.,
Thomas, S. M.,
Brugge, J. S.,
Halegoua, S.
(1995)
Neuron
15,
1415-1425[CrossRef][Medline]
[Order article via Infotrieve]
-
De Nichilo, M. O.,
and Yamada, K. M.
(1996)
J. Biol. Chem.
271,
11016-11022[Abstract/Free Full Text]
-
Brady-Kalnay, S. M.,
and Tonks, N. K.
(1995)
Curr. Opin. Cell Biol.
7,
650-657[CrossRef][Medline]
[Order article via Infotrieve]
-
Law, D. A.,
Nannizzi-Alaimo, L.,
and Phillips, D. R.
(1996)
J. Biol. Chem.
271,
10811-10815[Abstract/Free Full Text]
-
Rebut-Bonneton, C.,
Boutemy-Roulier, S.,
and Evain-Brion, D.
(1993)
J Cell Sci.
105,
629-636[Abstract]
-
Plopper, G. E.,
McNamee, H. P.,
Dike, L. E.,
Bojanowski, K.,
Ingber, D. E.
(1995)
Mol. Biol. Cell
6,
1349-1365[Abstract]
-
Clark, E. A.,
and Brugge, J. S.
(1993)
Mol. Cell. Biol.
13,
1863-1871[Abstract/Free Full Text]
-
Kobayashi, S.,
Okumura, N.,
Nakamoto, T.,
Okada, M.,
Hirai, H.,
and Nagai, K.
(1997)
J. Biol. Chem.
272,
16262-16267[Abstract/Free Full Text]
-
Erpel, T.,
and Courtneidge, S. A.
(1995)
Curr. Opin. Cell Biol.
7,
176-182[CrossRef][Medline]
[Order article via Infotrieve]
-
Hatai, M.,
Hashi, H.,
Mogi, A.,
Soga, H.,
Yokota, J.,
and Yaoi, Y.
(1994)
FEBS Lett.
350,
113-116[CrossRef][Medline]
[Order article via Infotrieve]
-
Nojima, Y.,
Morino, N.,
Mimura, T.,
Hamasaki, K.,
Furuya, H.,
Sakai, R.,
Sato, T.,
Tachibana, K.,
Morimoto, C.,
Yazaki, Y.,
and Hirai, H.
(1995)
J. Biol. Chem.
270,
15398-153402[Abstract/Free Full Text]
-
Rankin, S.,
Hooshmand-Rad, R.,
Claesson-Welsh, L.,
and Rozengurt, E.
(1996)
J. Biol. Chem.
271,
7829-7834[Abstract/Free Full Text]
-
Saito, Y.,
Mori, S.,
Yokote, K.,
Kanzaki, T.,
Saito, Y.,
and Morisaki, N.
(1996)
Biochem. Biophys. Res. Commun.
224,
23-26[CrossRef][Medline]
[Order article via Infotrieve]
-
Leventhal, P. S.,
and Feldman, E. L.
(1996)
J. Biol. Chem.
271,
5957-5960[Abstract/Free Full Text]
-
Seufferlein, T.,
and Rozengurt, E.
(1994)
J. Biol. Chem.
269,
9345-9351[Abstract/Free Full Text]
-
Zachary, I.,
Sinnett-Smith, J.,
Turner, C. E.,
Rozengurt, E.
(1993)
J. Biol. Chem.
268,
22060-22065[Abstract/Free Full Text]
-
Rankin, S.,
and Rozengurt, E.
(1994)
J. Biol. Chem.
269,
704-710[Abstract/Free Full Text]
-
Burridge, K.,
Turner, C. E.,
and Romer, L. H.
(1992)
J. Cell Biol.
119,
893-903[Abstract/Free Full Text]
-
Sakamoto, M.,
Ino, Y.,
Ochiai, A.,
Kanai, Y.,
Akimoto, S.,
and Hirohashi, S.
(1996)
Lab. Invest.
74,
199-208[Medline]
[Order article via Infotrieve]
-
Hildebrand, J. D.,
Schaller, M. D.,
Parsons, J. T.
(1995)
Mol. Biol. Cell
6,
637-647[Abstract]
-
Sabe, H.,
Hata, A.,
Okada, M.,
Nakagawa, H.,
and Hanafusa, H.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3984-3988[Abstract/Free Full Text]
-
Weng, Z.,
Taylor, J. A.,
Turner, C. E.,
Brugge, J. S.,
Seidel-Dugan, C.
(1993)
J. Biol. Chem.
268,
14956-14963[Abstract/Free Full Text]
-
Schaller, M. D.,
and Parsons, J. T.
(1995)
Mol. Cell. Biol.
15,
2635-2645[Abstract]
-
Gradl, G.,
Faust, D.,
Oesch, F.,
and Wieser, R. J.
(1995)
Curr. Biol.
5,
526-535[CrossRef][Medline]
[Order article via Infotrieve]
-
Singhvi, R.,
Kumar, A.,
Lopez, G. P.,
Stephanopoulos, G. N.,
Wang, D. I.,
Whitesides, G. M.,
Ingber, D. E.
(1994)
Science
264,
696-698[Abstract/Free Full Text]
-
Chen, C. S,
Mrksich, M.,
Huang, S.,
Whitesides, G. M.,
Ingber, D. E.
(1997)
Science
276,
1425-1428[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. He, J. Huang, C. F. Lagenaur, and E. Aizenman
Methylisothiazolinone, A Neurotoxic Biocide, Disrupts the Association of Src Family Tyrosine Kinases with Focal Adhesion Kinase in Developing Cortical Neurons
J. Pharmacol. Exp. Ther.,
June 1, 2006;
317(3):
1320 - 1329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xing, S. H. Ganji, J. W. Noh, and V. S. Kamanna
Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth
Am J Physiol Renal Physiol,
December 1, 2004;
287(6):
F1250 - F1257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Brown and C. E. Turner
Paxillin: Adapting to Change
Physiol Rev,
October 1, 2004;
84(4):
1315 - 1339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yan, Y. Lin, D. Yang, Y. Shen, M. Yuan, Z. Zhang, P. Li, H. Xia, L. Li, D. Luo, et al.
A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth
Blood,
July 1, 2003;
102(1):
184 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Taddei, P. Chiarugi, P. Cirri, F. Buricchi, T. Fiaschi, E. Giannoni, D. Talini, G. Cozzi, L. Formigli, G. Raugei, et al.
{beta}-Catenin Interacts with Low-Molecular-Weight Protein Tyrosine Phosphatase Leading to Cadherin-mediated Cell-Cell Adhesion Increase
Cancer Res.,
November 15, 2002;
62(22):
6489 - 6499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhang, M. Bewick, and R. M. Lafrenie
Role of Raf-1 and FAK in cell density-dependent regulation of integrin-dependent activation of MAP kinase
Carcinogenesis,
July 1, 2002;
23(7):
1251 - 1258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gennero, J. Fauvel, M. Nieto, C. Cariven, F. Gaits, F. Briand-Mesange, H. Chap, and J. P. Salles
Apoptotic Effect of Sphingosine 1-Phosphate and Increased Sphingosine 1-Phosphate Hydrolysis on Mesangial Cells Cultured at Low Cell Density
J. Biol. Chem.,
April 5, 2002;
277(15):
12724 - 12734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Sheta, M. A. Harding, M. R. Conaway, and D. Theodorescu
Focal Adhesion Kinase, Rap1, and Transcriptional Induction of Vascular Endothelial Growth Factor
J Natl Cancer Inst,
July 5, 2000;
92(13):
1065 - 1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. TAKAHASHI, K. TAKAHASHI, R. MERNAUGH, V. DROZDOFF, C. SIPE, H. SCHOECKLMANN, B. ROBERT, D. R. ABRAHAMSON, and T. O. DANIEL
Endothelial Localization of Receptor Tyrosine Phosphatase, ECRTP/DEP-1, in Developing and Mature Renal Vasculature
J. Am. Soc. Nephrol.,
October 1, 1999;
10(10):
2135 - 2145.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Anfosso, N. Bardin, V. Frances, E. Vivier, L. Camoin-Jau, J. Sampol, and F. Dignat-George
Activation of Human Endothelial Cells via S-Endo-1 Antigen (CD146) Stimulates the Tyrosine Phosphorylation of Focal Adhesion Kinase p125FAK
J. Biol. Chem.,
October 9, 1998;
273(41):
26852 - 26856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Noguchi, M. Tsuda, H. Takeda, T. Takada, K. Inagaki, T. Yamao, K. Fukunaga, T. Matozaki, and M. Kasuga
Inhibition of Cell Growth and Spreading by Stomach Cancer-associated Protein-tyrosine Phosphatase-1 (SAP-1) through Dephosphorylation of p130cas
J. Biol. Chem.,
April 27, 2001;
276(18):
15216 - 15224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Pani, R. Colavitti, B. Bedogni, R. Anzevino, S. Borrello, and T. Galeotti
A Redox Signaling Mechanism for Density-dependent Inhibition of Cell Growth
J. Biol. Chem.,
December 1, 2000;
275(49):
38891 - 38899.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|